Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies

Fortune•Mon, Jun 22, 2026, 09:00 PM•2 min read

“We want to be the SpaceX of the pharmaceutical industry,” Alex Zhavoronkov, co-CEO of Insilico Medicine tells Fortune.

Source: [Fortune](https://fortune.com/2026/06/22/insilico-sk-biopharmaceuticals-south-korea-ai-drug-discovery-spacex/)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

More Headlines

BusinessSeeking Alpha• 14m ago

Developing story — details emerging. Check the source link for the latest updates.

SportsYahoo Sports• 35m ago

The Knicks and restricted free agent Mohamed Diawara are working on a multiyear, eight-figure deal to bring the rookie back to New York.

BusinessBusiness Insider• 59m ago

A lifelong friend of Clive Davis and co-producer of his documentary says the late record producer had a prolific work ethic and attention to detail.

WorldAl Jazeera• 1h ago

Committee leaders did not release details but said the legislation would 'hold Big Tech accountable'.

WorldTimes of India• 1h ago

Developing story — details emerging. Check the source link for the latest updates.

BusinessFortune• 1h ago

Ten years after Brexit, GDP is down 8%, curry restaurants feel betrayed, and the prime minister just quit. Which is the Titanic metaphor for?